Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Shoenfeld's syndrome after pandemic influenza A/H1N1 vaccination.

Barros SM, Carvalho JF.

Acta Reumatol Port. 2011 Jan-Mar;36(1):65-8.

2.

ASIA or Shoenfeld's syndrome--an autoimmune syndrome induced by adjuvants.

Cojocaru M, Chicoş B.

Rom J Intern Med. 2013 Jul-Dec;51(3-4):131-4. Review.

PMID:
24620624
3.

Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.

Perdan-Pirkmajer K, Thallinger GG, Snoj N, Čučnik S, Žigon P, Kveder T, Logar D, Praprotnik S, Tomšič M, Sodin-Semrl S, Ambrožič A.

Lupus. 2012 Feb;21(2):175-83. doi: 10.1177/0961203311429817.

PMID:
22235050
4.

Asia or Shoenfeld's syndrome: highlighting different perspectives for diffuse chronic pain.

Carvalho JF, Barros SM, Branco JC, Fonseca JE.

Acta Reumatol Port. 2011 Jan-Mar;36(1):10-2. No abstract available.

5.

Pandemic 2009 influenza H1N1 virus vaccination: compliance and safety in a single hemodialysis center.

Stavroulopoulos A, Stamogiannos G, Aresti V.

Ren Fail. 2010;32(9):1044-8. doi: 10.3109/0886022X.2010.510232.

PMID:
20863207
6.

Seasonal influenza vaccination and the 2009 pandemic.

Mercer G, Kelly H.

Clin Infect Dis. 2011 Mar 15;52(6):828-9; author reply 830-1. doi: 10.1093/cid/cir035. No abstract available.

PMID:
21367738
7.

Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases.

Saad CG, Borba EF, Aikawa NE, Silva CA, Pereira RM, Calich AL, Moraes JC, Ribeiro AC, Viana VS, Pasoto SG, Carvalho JF, França IL, Guedes LK, Shinjo SK, Sampaio-Barros PD, Caleiro MT, Goncalves CR, Fuller R, Levy-Neto M, Timenetsky Mdo C, Precioso AR, Bonfa E.

Ann Rheum Dis. 2011 Jun;70(6):1068-73. doi: 10.1136/ard.2011.150250.

PMID:
21540203
8.

Mechanism for Seasonal Vaccine Effect on Pandemic H1N1 Risk Remains Uncertain.

Skowronski DM, Janjua NZ, Hottes TS, De Serres G.

Clin Infect Dis. 2011 Mar 15;52(6):831-2; author reply 832-3. doi: 10.1093/cid/cir036. No abstract available.

PMID:
21367740
10.

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).

Hanquet G, Van Damme P, Brasseur D, De Cuyper X, Gregor S, Holmberg M, Martin R, Molnár Z, Pompa MG, Snacken R, van der Sande M, Van Ranst M, Wirtz A, Neels P.

Vaccine. 2011 Jan 10;29(3):370-7. doi: 10.1016/j.vaccine.2010.10.079. Epub 2010 Nov 12.

PMID:
21075164
11.

Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.

Meyer S, Adam M, Schweiger B, Ilchmann C, Eulenburg C, Sattinger E, Runte H, Schlüter M, Deuse T, Reichenspurner H, Costard-Jäckle A.

Transplantation. 2011 May 15;91(9):1031-5. doi: 10.1097/TP.0b013e3182115be0.

PMID:
21358365
12.

Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine.

Chao DY, Cheng KF, Hsieh YH, Li TC, Wu TN, Chen CY, Tsai CA, Chen JH, Chiu HT, Lu JJ, Su MC, Liao YH; CIDER.

Vaccine. 2011 Jan 17;29(4):617-23. doi: 10.1016/j.vaccine.2010.11.016. Epub 2010 Nov 21.

PMID:
21095255
13.

Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients.

Labriola L, Hombrouck A, Maréchal C, Van Gucht S, Brochier B, Thomas I, Jadoul M, Goubau P.

Nephrol Dial Transplant. 2011 Apr;26(4):1424-8. doi: 10.1093/ndt/gfq782. Epub 2011 Jan 27.

PMID:
21273236
14.

[Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].

Press R, Andersen O.

Lakartidningen. 2010 Mar 10-16;107(10):666-7. Swedish. No abstract available.

PMID:
20402249
15.

Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld's syndrome).

Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P, Ramirez P, Gayosso-Rivera JA, Anduaga-Dominguez H, Lievana-Torres C, Jara LJ.

Lupus. 2012 Feb;21(2):128-35. doi: 10.1177/0961203311429317.

PMID:
22235042
16.

Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months.

Esposito S, Pugni L, Daleno C, Ronchi A, Valzano A, Serra D, Mosca F, Principi N.

Pediatrics. 2011 May;127(5):e1161-8. doi: 10.1542/peds.2010-1920. Epub 2011 Apr 4.

PMID:
21464195
17.

[Issues in vaccination against influenza A in Spain].

Bayas Rodríguez JM, García-Basteiro AL, Mena Pinilla G.

Arch Bronconeumol. 2010 Mar;46 Suppl 2:32-8. doi: 10.1016/S0300-2896(10)70018-1. Spanish.

18.

Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1241-5.

19.

Pandemic influenza A (H1N1) 2009 vaccine: an update.

Goel MK, Goel M, Khanna P, Mittal K.

Indian J Med Microbiol. 2011 Jan-Mar;29(1):13-8. doi: 10.4103/0255-0857.76517. Review.

20.

Vaccines against influenza A (H1N1) pandemic.

Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP.

Arch Med Res. 2009 Nov;40(8):693-704. doi: 10.1016/j.arcmed.2009.10.008.

PMID:
20304259

Supplemental Content

Support Center